- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.11.25 | Toronto Stock Exchange: VVT Medical Inc. (VVTM) Opens the Market | 256 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Erez Tetro, Chief Executive Officer, VVT Medical Inc. ("VVT", "VVT Medical", or the "Company") (TSXV: VVTM) and his team, joined Dani Lipkin... ► Artikel lesen | |
| 12.11.25 | VVT Med Inc: VVT Med enters $3.7-million distribution deal in India | 1 | Stockwatch | ||
| 11.11.25 | VVT Med Signs $3.7 Million Distribution Agreement in India, Achieves European Sales Milestone and Announces Proposed Debt Settlement | 1 | CNW | ||
| 29.10.25 | VVT Med receives order from NorthWell Health | 1 | Seeking Alpha | ||
| 29.10.25 | VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements | 3 | CNW | ||
| 13.08.25 | VVT Med Inc: VVT Med hires ITG for market-making services | 1 | Stockwatch | ||
| 13.08.25 | VVT Med Inc. Engages Independent Trading Group as Market Maker | 2 | CNW | ||
| 31.07.25 | VVT Med Inc: VVT Med starts trading on TSX-V | 2 | Stockwatch | ||
| VVT MED Aktie jetzt für 0€ handeln | |||||
| 31.07.25 | VVT Med Inc. Announces Commencement of Trading on TSX Venture Exchange | 2 | CNW | ||
| 23.07.25 | DXI Capital Corp: DXI Capital closes RTO, changes name to VVT Med | 2 | Stockwatch | ||
| 23.07.25 | VVT Med Inc. (Formerly DXI Capital Corp.) Completes Reverse Takeover of V.V.T. Med Ltd. and Exiteam Acquisition Corp | 720 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - VVT Med Inc. (TSXV: DXI.H) (formerly DXI Capital Corp.) (the "Company") is pleased to announce that it has completed its previously announced acquisition... ► Artikel lesen | |
| 17.07.25 | DXI Capital Corp: DXI Capital to roll back shares one for 4.67 July 18 | 2 | Stockwatch | ||
| 16.07.25 | DXI Capital Corp. Effects Share Consolidation and Name Change in Advance of Closing Proposed Reverse Takeover by V.V.T. Med Ltd. and Exiteam Acquisition Corp. | 326 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - Further to the transaction update provided in its press release dated June 30, 2025, DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to announce... ► Artikel lesen | |
| 01.07.25 | DXI Capital Corp. Provides Update on the Proposed Reverse Takeover by V.V.T. Med Ltd. and Exiteam Acquisition Corp. | 595 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to provide an update on its proposed acquisition of V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition... ► Artikel lesen | |
| 22.05.25 | DXI Capital Corp. Files Filing Statement for RTO Transaction | 475 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 21, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI"), V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition Corp. ("EAC", together with VVT and DXI, the "Parties")... ► Artikel lesen | |
| 25.03.25 | DXI Capital Corp., V.V.T. Med Ltd. and Exiteam Acquisition Corp. Announce Receipt of TSXV Conditional Approval for RTO Transaction | 622 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 25, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI"), V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition Corp. ("EAC", together with VVT and DXI, the "Parties")... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| UNITEDHEALTH | 298,05 | +1,85 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| DRAEGERWERK | 73,90 | +1,09 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Stärke | ||
| BOSTON SCIENTIFIC | 84,60 | +0,24 % | Boston Scientific reportedly plans to consolidate some Texas operations with new facility | ||
| PLUS THERAPEUTICS | 0,585 | -3,29 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ for Leptomeningeal Metastases | HOUSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| SPINEWAY | 0,190 | +1,06 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| ALIGNMENT HEALTHCARE | 20,950 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 31,990 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,480 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 33,470 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen |
Das Unternehmen VVT MED INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VVT MED INC finden Sie auf Wallstreet Online.